Results 1 to 10 of about 20 (20)

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

International Journal of Molecular Sciences, 2021
A-Hyeon Lee, Seung-Hoon Yang, Sang R. Lee   +2 more
exaly  

Multidisciplinary Considerations in the Maintenance Treatment of Poly(ADP-Ribose) Polymerase Inhibitors for Homologous Recombination-Proficient, Advanced-Stage Epithelial Ovarian Cancer

Ca-A Cancer Journal for Clinicians, 2023
Ilana Css
exaly  

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2021
exaly  

Immune Checkpoint Inhibitors May Be Safe for Patients With Preexisting Autoimmune Disease

Ca-A Cancer Journal for Clinicians, 2020
Mike Fillon
exaly  

Therapeutic Potential of TNFα Inhibitors in Chronic Inflammatory Disorders: Past and Future

Genes and Diseases, 2021
Hongtao Zhang, Yejia Zhang, Youhai H Chen   +2 more
exaly  

Poly(ADP-Ribose) Polymerase (PARP) Inhibitors: Exploiting a Synthetic Lethal Strategy in the Clinic

Ca-A Cancer Journal for Clinicians, 2011
Johann de Bono, Timothy A Yap, Shahneen K Sandhu   +2 more
exaly  

Few Physicians Prescribe 5-Alpha Reductase Inhibitors for Prostate Cancer Prevention

Ca-A Cancer Journal for Clinicians, 2011
Mary Kay Barton
exaly  

The Comparative Safety of TNF Inhibitors in Ankylosing Spondylitis—A Meta-Analysis Update of 14 Randomized Controlled Trials

Clinical Reviews in Allergy and Immunology, 2018
Li-Qiong Hou, Xiao-Guang Liu
exaly